Analyst Ims Investment Management Services Ltd. Biogen Inc. Transaction History
Analyst Ims Investment Management Services Ltd.
- $2.3 Billion
- Q1 2024
A detailed history of Analyst Ims Investment Management Services Ltd. transactions in Biogen Inc. stock. As of the latest transaction made, Analyst Ims Investment Management Services Ltd. holds 1,527 shares of BIIB stock, worth $344,567. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,527
Previous 1,488
2.62%
Holding current value
$344,567
Previous $385,000
14.55%
% of portfolio
0.01%
Previous 0.02%
Shares
14 transactions
Others Institutions Holding BIIB
# of Institutions
1,047Shares Held
126MCall Options Held
1.37MPut Options Held
1.35M-
Vanguard Group Inc Valley Forge, PA16.6MShares$3.74 Billion0.07% of portfolio
-
Primecap Management CO Pasadena, CA16.2MShares$3.66 Billion2.65% of portfolio
-
Black Rock Inc. New York, NY14.1MShares$3.19 Billion0.07% of portfolio
-
State Street Corp Boston, MA6.75MShares$1.52 Billion0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.17MShares$1.17 Billion0.68% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $32.5B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...